Skip to main content

Call for Submissions: 'Microbiome and Cancer' Collection

The Editors of BMC Cancer and BMC Microbiology are exited to announce the launch and invite of submissions to our ‘Microbiome and Cancer’ cross journal collection. Guest edited by Prof. Christopher Staley and Dr. Sean Devlin.


Open for submissions until 1st May 2021. Submit now!



Support and Guidance

Planning to submit a systematic review?

Prof Kelley provides a practical and stepwise approach for systematically reviewing the literature and publishing the results here

Submitting a study protocol?

Find out more about the journal's criteria and scope for study protocols here

Articles

Featured video: Microparticles, breast cancer's secret weapon?

Your browser needs to have JavaScript enabled to view this video

Read the article

Featured article: Are cancer patients better off if they participate in clinical trials?

How do physicians and nurses perceive the benefits of clinical trial participation compared with standard care? Is it justified to claim that clinical trial participation improves outcomes for cancer patients? Zandra Nielsen et al. present their latest findings of a mixed-methods study in Scandinavia.

Aims and scope

BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and clinical trials.

Journal Sections


Trending BMC Cancer Articles

Click here to view which Articles have been shared most in the last 6 months!

BMC Series Focus Issue

November: Diabetes

In support of World Diabetes Day on 14th November, this BMC Series focus issue places the spotlight on research advancing knowledge and patient care in diabetes. Our open-access content is available permanently, and highlights include genomics, neuroscience, and public health topics. 

Editorial: Nobel Prize Cancer Immunotherapy!

Follow Nobel Prize laureates James P. Allison's and Tasuku Honjo's footsteps and experience the genesis of a new field of cancer therapy. BMC Cancer Editorial Board Member Dr. Sheng Guo from Pittsburgh University takes us on an exciting journey of discovery...

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline

2019 Journal Metrics

  • Citation Impact
    3.15 -   2-year Impact Factor
    3.432 - 5-year Impact Factor
    1.021 - Source Normalized Impact per Paper (SNIP)
    1.186 - SCImago Journal Rank (SJR)

    Usage 

    4,151,734 downloads

    Social Media Impact 

    3364 mentions